CRCM LP

Institutional InvestorSimilar funds →SEC EDGAR: CIK 1483234
Institutional-grade research for retail investors

13F Reported Value

$141.2M

Holdings

8

Latest Filing

2026-03-31

Filing Quarter

Q1 2026

Portfolio Overview

CRCM LP disclosed 8 positions worth $141.2M in its Form 13F-HR for Q1 2026, led by $IAU (ISHARES GOLD TRUST) at 78.7% of the equity portfolio. During the quarter the fund opened 1 new position and exited 4 — including a new stake in $STAA and a full exit from $GRAL. The portfolio is most concentrated in Financials (79.9% of disclosed assets). All figures are sourced directly from CRCM LP’s Form 13F-HR filing with the SEC under CIK 1483234.

Sector Allocation

FinancialsOtherHealthcareConsumer Discretionary

AUM History

Top Equity Holdings by Value

Quarterly Activity — Q1 2026

Click any card to unlock

Top Holdings

AI Quality Scored

Unlock AI quality scores for every holding

32-signal composite ranking on each of CRCM LP's 8 positions.

Showing top 8 of 8 holdings.

Sector Allocation

Financials

$112.9M

Other

$14.0M

Healthcare

$7.7M

Consumer Discretionary

$6.6M

Full Holdings — CRCM LP (Q1 2026)

All 8 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.

#TickerCompanyValueWeightQoQQuality
1IAU$IAUISHARES GOLD TRUST$111.1M78.7%+74%
2ALT5 SIGMA CORP$14.0M9.9%+15%
3PLBY$PLBYPlayboy, Inc.$6.6M4.7%+18%23.7
4BNR$BNRBurning Rock Biotech Ltd$4.6M3.3%-43%
5STAA$STAASTAAR SURGICAL CO$1.9M1.3%NEW18
6PCAP$PCAPProCap Acquisition Corp$1.6M1.1%-50%
7PCSC$PCSCPerceptive Capital Solutions Corp$1.3M0.9%-72%
8USBC$USBCUSBC, Inc.$214,4110.1%-78%

New Positions (1)

STAA$STAA STAAR SURGICAL CO$1.9M

Exited Positions (4)

GRAL$GRAL GRAIL, Inc.
HHH$HHH Howard Hughes Holdings Inc.
WBD$WBD Warner Bros. Discovery, Inc.
RNA$RNA Avidity Biosciences, Inc.

Browse Top Institutional Investors

13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.

to search all 8,700+ institutional filers.

Available Analysis

13F Pro tracks comprehensive institutional data for CRCM LP including:

Full 13F portfolio with all holdings
Quarter-over-quarter position changes
Accumulation & distribution patterns
Sector allocation breakdown
Historical portfolio evolution
New positions & complete exits
Concentration analysis
Peer comparison with similar funds
AI-powered portfolio insights

Track CRCM LP's Full Portfolio

See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for CRCM LP and 8,700+ other institutional investors.

View Pricing

Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

AI-Powered Hedge Fund Analysis: CRCM LP

13F Pro is an AI hedge fund tracker and stock research platform. For CRCM LP (SEC CIK: 1483234), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.

Every holding in CRCM LP's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.